Trident Lifeline's Shareholding in Subsidiary Trident Mediquip Reduces to 57.34% After Private Placement

1 min read     Updated on 03 Mar 2026, 04:06 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Trident Lifeline Limited's shareholding in subsidiary Trident Mediquip Limited has decreased from 60.04% to 57.34% following a private placement of equity shares to other shareholders. Trident Mediquip, incorporated in 2019, operates in the pharmaceuticals and chemical industry with a current turnover of 21.29 crores and paid-up share capital of Rs. 9.78 crores. The transaction has been disclosed under SEBI regulations as a related party transaction conducted on an arm's length basis.

34079818

*this image is generated using AI for illustrative purposes only.

Trident Lifeline Limited has reported a reduction in its shareholding in subsidiary Trident Mediquip Limited following a private placement transaction. The company's stake in the subsidiary has decreased from 60.04% to 57.34% after Trident Mediquip Limited allotted equity shares to other shareholders.

Shareholding Change Details

The change in shareholding occurred due to a private placement of equity shares by Trident Mediquip Limited to other shareholders. This transaction has resulted in a dilution of Trident Lifeline's ownership stake in its subsidiary.

Parameter: Details
Pre-holding: 60.04%
Post-holding: 57.34%
Transaction Type: Private Placement
Regulatory Filing: Under Regulation 30 of SEBI (LODR)

About Trident Mediquip Limited

Trident Mediquip Limited is a subsidiary company incorporated under the Companies Act, 2013, with its registered office in Surat, Gujarat. The company operates in the pharmaceuticals and chemical industry and was incorporated on October 19, 2019.

Financial Structure

Financial Parameter: Amount
Authorized Share Capital: Rs. 10.00 crores
Paid-up Share Capital: Rs. 9.78 crores
Number of Equity Shares: 97,75,800 shares
Face Value per Share: Rs. 10
Current Turnover: 21.29 crores

Historical Performance

Trident Mediquip Limited's turnover performance over the last three financial years shows:

Financial Year: Turnover
2022-23: 28.77 crores
2023-24: 20.58 crores
2024-25: 21.29 crores

Related Party Transaction

The transaction qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. The filing indicates that several promoters and directors of Trident Lifeline Limited, including Mr. Amit Bhupendra Halvawala, Mr. Chetan Chandrakant Jariwala, and Mr. Hardik Jigishkumar Desai, have interests in the subsidiary. The company has confirmed that the transaction is being undertaken on an arm's length basis.

Regulatory Compliance

Trident Lifeline Limited has filed the necessary disclosures under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also complied with SEBI Master Circular requirements in making this announcement to the stock exchanges.

Historical Stock Returns for Trident Lifeline

1 Day5 Days1 Month6 Months1 Year5 Years
-0.37%+1.96%-11.81%-6.13%+19.11%+147.80%

Hardik Desai Family Trust Increases Stake in Trident Lifeline Limited to 6.99%

1 min read     Updated on 23 Feb 2026, 04:17 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Hardik Desai Family Trust disclosed the acquisition of 1,200 additional shares in Trident Lifeline Limited through open market purchase on 20.02.2026. The acquisition increased the promoter group entity's holding from 8,32,766 shares (6.98%) to 8,33,966 shares (6.99%), representing a marginal 0.01% increase. The disclosure was made under SEBI regulations, with the company maintaining its equity share capital at Rs. 11,93,30,000 comprising 1,19,33,000 shares of Rs. 10 each.

33389247

*this image is generated using AI for illustrative purposes only.

Trident Lifeline Limited has received a disclosure from Hardik Desai Family Trust regarding the acquisition of additional shares under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The trust, operating through its Ultimate Beneficial Owner Hardik Jigishkumar Desai, belongs to the promoter group category.

Share Acquisition Details

The trust acquired 1,200 shares through open market purchase on 20.02.2026. This transaction represents a minimal increase of 0.01% in both total share capital and diluted share capital terms.

Transaction Details: Value
Shares Acquired: 1,200
Acquisition Mode: Open Market
Transaction Date: 20.02.2026
Percentage Increase: 0.01%

Holdings Comparison

The acquisition resulted in a marginal increase in the trust's shareholding position in the company.

Holding Period: Number of Shares % of Total Capital % of Diluted Capital
Before Acquisition: 8,32,766 6.98% 6.66%
After Acquisition: 8,33,966 6.99% 6.67%
Net Change: +1,200 +0.01% +0.01%

Company Capital Structure

Trident Lifeline Limited maintains a stable capital structure with no changes reported in the equity share capital following this transaction.

Capital Component: Details
Equity Share Capital: Rs. 11,93,30,000
Number of Equity Shares: 1,19,33,000
Face Value per Share: Rs. 10
Total Diluted Capital: Rs. 12,49,34,000
Diluted Shares: 1,24,93,400

The disclosure was filed in compliance with SEBI regulations, with the company's shares listed on BSE Limited. The trust's registered address is located at 01 Seema Row House, Ghod Dod Road, Umra, Surat City, Gujarat.

Historical Stock Returns for Trident Lifeline

1 Day5 Days1 Month6 Months1 Year5 Years
-0.37%+1.96%-11.81%-6.13%+19.11%+147.80%

More News on Trident Lifeline

1 Year Returns:+19.11%